In this study, we aimed to measure the expression of NE in serum, and to evaluate NE as a CRC marker for assisting early diagnosis and use a NE inhibitor sivelestat as an alternative therapeutic agent to treat colorectal cancers. The gene discussed is ELANE; the disease is colorectal carcinoma.